Summit Therapeu ADR SMMT

$15.07 -1.57 (-9.44%)

Valuation

Market cap
13,308,072,000
Revenue TTM
$0
Net income TTM
$-1,079,590,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
3,874,200
Avg volume
6,225,926
Day's range
$14.98 – $16.44
Shares out
799,764,000
Stochastic %K
23%
Beta
-1.49
Analysts
Moderate Buy
Price target
$28.96

Price

Company profile

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company...

Show more

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.

Industry
Biotechnology
Sector
Healthcare
Phone
305 203 2034
Website
https://www.smmttx.com
Address
601 Brickell Key Drive, Suite 1000, Miami, United States

Latest news

Stocktwits

BigBeardTrader Nov 13, 3:44 PM
$SMMT Whales buying the dip.
0 replies
TruthBroker2 Nov 13, 3:30 PM
$SMMT Shorts are Nervous its showing .
1 replies
SlaveLifeAllLife Nov 13, 3:23 PM
$SMMT Sorry, i think this will drop 80%.
4 replies
BigBeardTrader Nov 13, 3:12 PM
$SMMT Well, every other news release was met with FOMO except this one. Probably a good sign considering every other time it sold off heavily after the release, maybe it will do the opposite this time.
2 replies
Isarheml Nov 13, 3:08 PM
$SMMT are you selling before the readout?
1 replies
regimecard Nov 13, 3:03 PM
$SMMT Regime check: the US market closed at 15.6, MILDLY OFF, on Nov 12. How SMMT has done in MILDLY OFF markets: a typical 3-month return of -6.5%, history only. With the reading in MILDLY OFF for a run of sessions, SMMT sits in the stream as one of the names traders on this week's most-wanted list are checking against the regime.
0 replies
letstalk8 Nov 13, 2:41 PM
$SMMT lets try and answer this with real data a complete response letter would require Summit to generate additional data — MOST LIKELY, statistically significant OS benefit — before resubmitting. Given the current OS trajectory (HR 0.76, p not significant), that would LIKELY require another 12 to 18 months of follow-up at minimum. Just my opinion.
1 replies
Winttard Nov 13, 2:37 PM
$SMMT i am super surprised if this price action. They are shorting it into a PDUFA
1 replies